Multiple Sclerosis Therapeutics 2011
DOI: 10.1017/cbo9781139023986.065
|View full text |Cite
|
Sign up to set email alerts
|

Rehabilitation in multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 54 publications
0
3
0
Order By: Relevance
“…33 Furthermore, motor fatigue, which is characterized by failure to sustain the force of muscle contractions, is also hypothesized to contribute to a decreased result on repetitive or longer lasting tasks such as the 6MWT/2MWT. 34 The 6MWT has been demonstrated to be reliable and valid, 22,35 and also sensitive to change as a result of rehabilitation interventions targeting walking ability in chronic stroke and MS. 36,37 Its minimally important change (MIC) for deterioration from the clinician's perspective (which reflects the smallest difference in outcome that signifies an important rather than trivial difference in the clinician's rating) amounts to -55 metres; 38 when extrapolated to the present study, this equals a decrease of 582 strides on a daily basis in the total sample (obtained by MIC*-value). The 6MWT is considered to be a feasible clinical test as only one test execution is required since no practice effects were found in stroke patients and pwMS.…”
Section: Discussionmentioning
confidence: 99%
“…33 Furthermore, motor fatigue, which is characterized by failure to sustain the force of muscle contractions, is also hypothesized to contribute to a decreased result on repetitive or longer lasting tasks such as the 6MWT/2MWT. 34 The 6MWT has been demonstrated to be reliable and valid, 22,35 and also sensitive to change as a result of rehabilitation interventions targeting walking ability in chronic stroke and MS. 36,37 Its minimally important change (MIC) for deterioration from the clinician's perspective (which reflects the smallest difference in outcome that signifies an important rather than trivial difference in the clinician's rating) amounts to -55 metres; 38 when extrapolated to the present study, this equals a decrease of 582 strides on a daily basis in the total sample (obtained by MIC*-value). The 6MWT is considered to be a feasible clinical test as only one test execution is required since no practice effects were found in stroke patients and pwMS.…”
Section: Discussionmentioning
confidence: 99%
“…Depression was measured by Patient Health Questionnaire‐9 (PHQ‐9) . Fatigue severity was assessed with Modified Fatigue Impact Scale (MFIS) .…”
Section: Methodsmentioning
confidence: 99%
“…The prevalence of fatigue in MS ranges from 70% to 90%. 6 A large survey revealed that almost all patients report to be most fatigued in the afternoon or evening. 7 This diurnal increase of self-reported fatigue has been confirmed in clinical trials.…”
Section: Introductionmentioning
confidence: 99%